Skip to content
Predicting long term lung health outcomes in young adults born very preterm (WALHIP 19 year old follow-up)

This study will conduct a detailed lung health assessment in a follow-up of a group of preterm individuals at 19 years of age.

LIFECYCLE - Early Life Stressors and LifeCycle Health

LIFECYCLE is a significant and visionary project to establish an integrated set of long-term world-wide cohorts and clinical trials, which can be investigated and compared across the full life of cohort participants.

Developing clinical predictors of disease progression in children with neuromuscular disorders to prevent future respiratory failure

Graham Hall BAppSci PhD CRFS FANZSRS FThorSoc FERS Honorary Research Associate Honorary Research Associate Professor Graham Hall is an internationally recognised respiratory physiologist and former Co-Head of Children’s Lung Health at The Kids

Biomarkers to define the treatment end-point for pulmonary exacerbations in cystic fibrosis

Advances in our understanding of early cystic fibrosis lung disease led by the Australian Early Surveillance Team for Cystic Fibrosis (AREST CF) have also indicated the potential utility of a number of biomarkers for monitoring disease severity.

PREDICT CF: Assessing the role of lung clearance index in predicting disease progression in children with cystic fibrosis

There is increasing evidence that the assessment of ventilation distribution using the multiple breath washout (MBW) technique is sensitive to changes in disease status of children with cystic fibrosis.